EVH Q2 2026 Deep Dive: Oncology Suite and AI Automation Drive Growth Amid Membership Headwinds Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations , with sales up 46.9% year on year to $652.5 million. The company’s full-year revenue guidance of $2.65 billion at the midpoint came in 5.9%…